nodes	percent_of_prediction	percent_of_DWPC	metapath
Lansoprazole—CYP1B1—glaucoma	0.406	1	CbGaD
Lansoprazole—CYP1A1—Clonidine—glaucoma	0.0304	0.0894	CbGbCtD
Lansoprazole—CYP2D6—Carteolol—glaucoma	0.0302	0.0889	CbGbCtD
Lansoprazole—CYP1A2—Betaxolol—glaucoma	0.0248	0.0729	CbGbCtD
Lansoprazole—CYP2D6—Betaxolol—glaucoma	0.0204	0.06	CbGbCtD
Lansoprazole—CYP2C19—Methazolamide—glaucoma	0.0204	0.0598	CbGbCtD
Lansoprazole—CYP2C9—Diclofenamide—glaucoma	0.0197	0.0578	CbGbCtD
Lansoprazole—CYP2C9—Dorzolamide—glaucoma	0.019	0.0558	CbGbCtD
Lansoprazole—CYP2C19—Timolol—glaucoma	0.0173	0.0509	CbGbCtD
Lansoprazole—CYP2C9—Methazolamide—glaucoma	0.0169	0.0498	CbGbCtD
Lansoprazole—CYP2D6—Methazolamide—glaucoma	0.0155	0.0455	CbGbCtD
Lansoprazole—CYP3A4—Pilocarpine—glaucoma	0.0146	0.0428	CbGbCtD
Lansoprazole—ABCB1—Timolol—glaucoma	0.014	0.0411	CbGbCtD
Lansoprazole—CYP1A2—Clonidine—glaucoma	0.0136	0.0399	CbGbCtD
Lansoprazole—CYP2D6—Timolol—glaucoma	0.0132	0.0387	CbGbCtD
Lansoprazole—ABCB1—Clonidine—glaucoma	0.0119	0.0349	CbGbCtD
Lansoprazole—CYP3A4—Brinzolamide—glaucoma	0.0114	0.0336	CbGbCtD
Lansoprazole—CYP2D6—Clonidine—glaucoma	0.0112	0.0329	CbGbCtD
Lansoprazole—CYP3A4—Dorzolamide—glaucoma	0.011	0.0325	CbGbCtD
Lansoprazole—CYP3A4—Methazolamide—glaucoma	0.00984	0.0289	CbGbCtD
Lansoprazole—CYP3A4—Acetazolamide—glaucoma	0.00787	0.0231	CbGbCtD
Lansoprazole—CYP3A4—Clonidine—glaucoma	0.00712	0.0209	CbGbCtD
Lansoprazole—Omeprazole—CYP1B1—glaucoma	0.00117	1	CrCbGaD
Lansoprazole—Feeling abnormal—Brinzolamide—glaucoma	7.51e-05	0.000362	CcSEcCtD
Lansoprazole—Mental disorder—Betaxolol—glaucoma	7.51e-05	0.000362	CcSEcCtD
Lansoprazole—Pain—Pilocarpine—glaucoma	7.49e-05	0.000361	CcSEcCtD
Lansoprazole—Constipation—Pilocarpine—glaucoma	7.49e-05	0.000361	CcSEcCtD
Lansoprazole—Cough—Clonidine—glaucoma	7.48e-05	0.000361	CcSEcCtD
Lansoprazole—Sweating—Timolol—glaucoma	7.48e-05	0.000361	CcSEcCtD
Lansoprazole—Dizziness—Apraclonidine—glaucoma	7.48e-05	0.000361	CcSEcCtD
Lansoprazole—Erythema—Betaxolol—glaucoma	7.46e-05	0.00036	CcSEcCtD
Lansoprazole—Malnutrition—Betaxolol—glaucoma	7.46e-05	0.00036	CcSEcCtD
Lansoprazole—Urticaria—Dorzolamide—glaucoma	7.36e-05	0.000355	CcSEcCtD
Lansoprazole—Epistaxis—Timolol—glaucoma	7.36e-05	0.000355	CcSEcCtD
Lansoprazole—Body temperature increased—Dorzolamide—glaucoma	7.33e-05	0.000353	CcSEcCtD
Lansoprazole—Abdominal pain—Dorzolamide—glaucoma	7.33e-05	0.000353	CcSEcCtD
Lansoprazole—Tension—Betaxolol—glaucoma	7.32e-05	0.000353	CcSEcCtD
Lansoprazole—Sinusitis—Timolol—glaucoma	7.32e-05	0.000353	CcSEcCtD
Lansoprazole—Dysgeusia—Betaxolol—glaucoma	7.31e-05	0.000352	CcSEcCtD
Lansoprazole—Chest pain—Clonidine—glaucoma	7.3e-05	0.000352	CcSEcCtD
Lansoprazole—Arthralgia—Clonidine—glaucoma	7.3e-05	0.000352	CcSEcCtD
Lansoprazole—Abdominal pain—Travoprost—glaucoma	7.3e-05	0.000352	CcSEcCtD
Lansoprazole—Agranulocytosis—Timolol—glaucoma	7.28e-05	0.000351	CcSEcCtD
Lansoprazole—Anxiety—Clonidine—glaucoma	7.27e-05	0.000351	CcSEcCtD
Lansoprazole—Asthenia—Acetazolamide—glaucoma	7.26e-05	0.00035	CcSEcCtD
Lansoprazole—Dizziness—Bimatoprost—glaucoma	7.25e-05	0.00035	CcSEcCtD
Lansoprazole—Nervousness—Betaxolol—glaucoma	7.25e-05	0.000349	CcSEcCtD
Lansoprazole—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	7.25e-05	0.000349	CcSEcCtD
Lansoprazole—Urticaria—Brinzolamide—glaucoma	7.24e-05	0.000349	CcSEcCtD
Lansoprazole—Feeling abnormal—Pilocarpine—glaucoma	7.22e-05	0.000348	CcSEcCtD
Lansoprazole—Discomfort—Clonidine—glaucoma	7.21e-05	0.000348	CcSEcCtD
Lansoprazole—Vomiting—Apraclonidine—glaucoma	7.19e-05	0.000347	CcSEcCtD
Lansoprazole—Muscle spasms—Betaxolol—glaucoma	7.17e-05	0.000346	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Pilocarpine—glaucoma	7.16e-05	0.000345	CcSEcCtD
Lansoprazole—Hypersensitivity—Brimonidine—glaucoma	7.15e-05	0.000345	CcSEcCtD
Lansoprazole—Dry mouth—Clonidine—glaucoma	7.14e-05	0.000344	CcSEcCtD
Lansoprazole—Bradycardia—Timolol—glaucoma	7.13e-05	0.000344	CcSEcCtD
Lansoprazole—Dermatitis—Apraclonidine—glaucoma	7.12e-05	0.000343	CcSEcCtD
Lansoprazole—Headache—Apraclonidine—glaucoma	7.08e-05	0.000342	CcSEcCtD
Lansoprazole—Confusional state—Clonidine—glaucoma	7.05e-05	0.00034	CcSEcCtD
Lansoprazole—Vision blurred—Betaxolol—glaucoma	7.03e-05	0.000339	CcSEcCtD
Lansoprazole—Rhinitis—Timolol—glaucoma	7.02e-05	0.000339	CcSEcCtD
Lansoprazole—Oedema—Clonidine—glaucoma	6.99e-05	0.000337	CcSEcCtD
Lansoprazole—Tremor—Betaxolol—glaucoma	6.99e-05	0.000337	CcSEcCtD
Lansoprazole—Hallucination—Timolol—glaucoma	6.97e-05	0.000336	CcSEcCtD
Lansoprazole—Asthenia—Brimonidine—glaucoma	6.96e-05	0.000336	CcSEcCtD
Lansoprazole—Infection—Clonidine—glaucoma	6.95e-05	0.000335	CcSEcCtD
Lansoprazole—Body temperature increased—Pilocarpine—glaucoma	6.92e-05	0.000334	CcSEcCtD
Lansoprazole—Abdominal pain—Pilocarpine—glaucoma	6.92e-05	0.000334	CcSEcCtD
Lansoprazole—Ill-defined disorder—Betaxolol—glaucoma	6.92e-05	0.000334	CcSEcCtD
Lansoprazole—Diarrhoea—Acetazolamide—glaucoma	6.92e-05	0.000334	CcSEcCtD
Lansoprazole—Rash—Bimatoprost—glaucoma	6.91e-05	0.000333	CcSEcCtD
Lansoprazole—Dermatitis—Bimatoprost—glaucoma	6.91e-05	0.000333	CcSEcCtD
Lansoprazole—Oedema peripheral—Timolol—glaucoma	6.9e-05	0.000333	CcSEcCtD
Lansoprazole—Anaemia—Betaxolol—glaucoma	6.9e-05	0.000333	CcSEcCtD
Lansoprazole—Shock—Clonidine—glaucoma	6.88e-05	0.000332	CcSEcCtD
Lansoprazole—Connective tissue disorder—Timolol—glaucoma	6.88e-05	0.000332	CcSEcCtD
Lansoprazole—Pruritus—Brimonidine—glaucoma	6.87e-05	0.000331	CcSEcCtD
Lansoprazole—Headache—Bimatoprost—glaucoma	6.87e-05	0.000331	CcSEcCtD
Lansoprazole—Nervous system disorder—Clonidine—glaucoma	6.86e-05	0.000331	CcSEcCtD
Lansoprazole—Thrombocytopenia—Clonidine—glaucoma	6.85e-05	0.00033	CcSEcCtD
Lansoprazole—Hypersensitivity—Dorzolamide—glaucoma	6.83e-05	0.000329	CcSEcCtD
Lansoprazole—Tachycardia—Clonidine—glaucoma	6.83e-05	0.000329	CcSEcCtD
Lansoprazole—Hypersensitivity—Travoprost—glaucoma	6.8e-05	0.000328	CcSEcCtD
Lansoprazole—Skin disorder—Clonidine—glaucoma	6.79e-05	0.000328	CcSEcCtD
Lansoprazole—Hyperhidrosis—Clonidine—glaucoma	6.76e-05	0.000326	CcSEcCtD
Lansoprazole—Visual impairment—Timolol—glaucoma	6.75e-05	0.000325	CcSEcCtD
Lansoprazole—Malaise—Betaxolol—glaucoma	6.73e-05	0.000324	CcSEcCtD
Lansoprazole—Nausea—Apraclonidine—glaucoma	6.72e-05	0.000324	CcSEcCtD
Lansoprazole—Hypersensitivity—Brinzolamide—glaucoma	6.71e-05	0.000324	CcSEcCtD
Lansoprazole—Vertigo—Betaxolol—glaucoma	6.7e-05	0.000323	CcSEcCtD
Lansoprazole—Syncope—Betaxolol—glaucoma	6.69e-05	0.000323	CcSEcCtD
Lansoprazole—Dizziness—Acetazolamide—glaucoma	6.69e-05	0.000322	CcSEcCtD
Lansoprazole—Anorexia—Clonidine—glaucoma	6.67e-05	0.000322	CcSEcCtD
Lansoprazole—Asthenia—Dorzolamide—glaucoma	6.65e-05	0.000321	CcSEcCtD
Lansoprazole—Asthenia—Travoprost—glaucoma	6.62e-05	0.000319	CcSEcCtD
Lansoprazole—Palpitations—Betaxolol—glaucoma	6.59e-05	0.000318	CcSEcCtD
Lansoprazole—Pruritus—Dorzolamide—glaucoma	6.56e-05	0.000316	CcSEcCtD
Lansoprazole—Loss of consciousness—Betaxolol—glaucoma	6.56e-05	0.000316	CcSEcCtD
Lansoprazole—Eye disorder—Timolol—glaucoma	6.54e-05	0.000316	CcSEcCtD
Lansoprazole—Asthenia—Brinzolamide—glaucoma	6.54e-05	0.000315	CcSEcCtD
Lansoprazole—Hypotension—Clonidine—glaucoma	6.54e-05	0.000315	CcSEcCtD
Lansoprazole—Pruritus—Travoprost—glaucoma	6.53e-05	0.000315	CcSEcCtD
Lansoprazole—Tinnitus—Timolol—glaucoma	6.53e-05	0.000315	CcSEcCtD
Lansoprazole—Cough—Betaxolol—glaucoma	6.51e-05	0.000314	CcSEcCtD
Lansoprazole—Nausea—Bimatoprost—glaucoma	6.51e-05	0.000314	CcSEcCtD
Lansoprazole—Cardiac disorder—Timolol—glaucoma	6.5e-05	0.000313	CcSEcCtD
Lansoprazole—Hypersensitivity—Pilocarpine—glaucoma	6.45e-05	0.000311	CcSEcCtD
Lansoprazole—Pruritus—Brinzolamide—glaucoma	6.45e-05	0.000311	CcSEcCtD
Lansoprazole—Vomiting—Acetazolamide—glaucoma	6.43e-05	0.00031	CcSEcCtD
Lansoprazole—Dizziness—Brimonidine—glaucoma	6.42e-05	0.000309	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Clonidine—glaucoma	6.37e-05	0.000307	CcSEcCtD
Lansoprazole—Angiopathy—Timolol—glaucoma	6.35e-05	0.000306	CcSEcCtD
Lansoprazole—Chest pain—Betaxolol—glaucoma	6.35e-05	0.000306	CcSEcCtD
Lansoprazole—Myalgia—Betaxolol—glaucoma	6.35e-05	0.000306	CcSEcCtD
Lansoprazole—Arthralgia—Betaxolol—glaucoma	6.35e-05	0.000306	CcSEcCtD
Lansoprazole—Diarrhoea—Dorzolamide—glaucoma	6.34e-05	0.000306	CcSEcCtD
Lansoprazole—Headache—Acetazolamide—glaucoma	6.34e-05	0.000305	CcSEcCtD
Lansoprazole—Anxiety—Betaxolol—glaucoma	6.33e-05	0.000305	CcSEcCtD
Lansoprazole—Insomnia—Clonidine—glaucoma	6.33e-05	0.000305	CcSEcCtD
Lansoprazole—Immune system disorder—Timolol—glaucoma	6.32e-05	0.000305	CcSEcCtD
Lansoprazole—Diarrhoea—Travoprost—glaucoma	6.32e-05	0.000305	CcSEcCtD
Lansoprazole—Mediastinal disorder—Timolol—glaucoma	6.31e-05	0.000304	CcSEcCtD
Lansoprazole—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	6.31e-05	0.000304	CcSEcCtD
Lansoprazole—Asthenia—Pilocarpine—glaucoma	6.28e-05	0.000303	CcSEcCtD
Lansoprazole—Paraesthesia—Clonidine—glaucoma	6.28e-05	0.000303	CcSEcCtD
Lansoprazole—Discomfort—Betaxolol—glaucoma	6.28e-05	0.000303	CcSEcCtD
Lansoprazole—Arrhythmia—Timolol—glaucoma	6.26e-05	0.000302	CcSEcCtD
Lansoprazole—Dyspnoea—Clonidine—glaucoma	6.24e-05	0.000301	CcSEcCtD
Lansoprazole—Diarrhoea—Brinzolamide—glaucoma	6.24e-05	0.000301	CcSEcCtD
Lansoprazole—Somnolence—Clonidine—glaucoma	6.22e-05	0.0003	CcSEcCtD
Lansoprazole—Dry mouth—Betaxolol—glaucoma	6.21e-05	0.0003	CcSEcCtD
Lansoprazole—Pruritus—Pilocarpine—glaucoma	6.2e-05	0.000299	CcSEcCtD
Lansoprazole—Alopecia—Timolol—glaucoma	6.19e-05	0.000298	CcSEcCtD
Lansoprazole—Confusional state—Betaxolol—glaucoma	6.14e-05	0.000296	CcSEcCtD
Lansoprazole—Mental disorder—Timolol—glaucoma	6.13e-05	0.000296	CcSEcCtD
Lansoprazole—Dizziness—Dorzolamide—glaucoma	6.13e-05	0.000296	CcSEcCtD
Lansoprazole—Rash—Brimonidine—glaucoma	6.12e-05	0.000295	CcSEcCtD
Lansoprazole—Dermatitis—Brimonidine—glaucoma	6.11e-05	0.000295	CcSEcCtD
Lansoprazole—Dizziness—Travoprost—glaucoma	6.1e-05	0.000294	CcSEcCtD
Lansoprazole—Erythema—Timolol—glaucoma	6.1e-05	0.000294	CcSEcCtD
Lansoprazole—Malnutrition—Timolol—glaucoma	6.1e-05	0.000294	CcSEcCtD
Lansoprazole—Oedema—Betaxolol—glaucoma	6.09e-05	0.000294	CcSEcCtD
Lansoprazole—Headache—Brimonidine—glaucoma	6.08e-05	0.000293	CcSEcCtD
Lansoprazole—Decreased appetite—Clonidine—glaucoma	6.08e-05	0.000293	CcSEcCtD
Lansoprazole—Infection—Betaxolol—glaucoma	6.05e-05	0.000292	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Clonidine—glaucoma	6.04e-05	0.000291	CcSEcCtD
Lansoprazole—Fatigue—Clonidine—glaucoma	6.03e-05	0.000291	CcSEcCtD
Lansoprazole—Dizziness—Brinzolamide—glaucoma	6.03e-05	0.000291	CcSEcCtD
Lansoprazole—Nausea—Acetazolamide—glaucoma	6.01e-05	0.00029	CcSEcCtD
Lansoprazole—Diarrhoea—Pilocarpine—glaucoma	5.99e-05	0.000289	CcSEcCtD
Lansoprazole—Shock—Betaxolol—glaucoma	5.99e-05	0.000289	CcSEcCtD
Lansoprazole—Tension—Timolol—glaucoma	5.98e-05	0.000288	CcSEcCtD
Lansoprazole—Constipation—Clonidine—glaucoma	5.98e-05	0.000288	CcSEcCtD
Lansoprazole—Pain—Clonidine—glaucoma	5.98e-05	0.000288	CcSEcCtD
Lansoprazole—Nervous system disorder—Betaxolol—glaucoma	5.97e-05	0.000288	CcSEcCtD
Lansoprazole—Dysgeusia—Timolol—glaucoma	5.97e-05	0.000288	CcSEcCtD
Lansoprazole—Thrombocytopenia—Betaxolol—glaucoma	5.96e-05	0.000288	CcSEcCtD
Lansoprazole—Tachycardia—Betaxolol—glaucoma	5.94e-05	0.000287	CcSEcCtD
Lansoprazole—Nervousness—Timolol—glaucoma	5.92e-05	0.000285	CcSEcCtD
Lansoprazole—Skin disorder—Betaxolol—glaucoma	5.92e-05	0.000285	CcSEcCtD
Lansoprazole—Vomiting—Dorzolamide—glaucoma	5.89e-05	0.000284	CcSEcCtD
Lansoprazole—Hyperhidrosis—Betaxolol—glaucoma	5.89e-05	0.000284	CcSEcCtD
Lansoprazole—Rash—Dorzolamide—glaucoma	5.84e-05	0.000282	CcSEcCtD
Lansoprazole—Dermatitis—Dorzolamide—glaucoma	5.84e-05	0.000282	CcSEcCtD
Lansoprazole—Rash—Travoprost—glaucoma	5.82e-05	0.000281	CcSEcCtD
Lansoprazole—Dermatitis—Travoprost—glaucoma	5.81e-05	0.00028	CcSEcCtD
Lansoprazole—Headache—Dorzolamide—glaucoma	5.81e-05	0.00028	CcSEcCtD
Lansoprazole—Anorexia—Betaxolol—glaucoma	5.8e-05	0.00028	CcSEcCtD
Lansoprazole—Vomiting—Brinzolamide—glaucoma	5.79e-05	0.000279	CcSEcCtD
Lansoprazole—Dizziness—Pilocarpine—glaucoma	5.79e-05	0.000279	CcSEcCtD
Lansoprazole—Headache—Travoprost—glaucoma	5.78e-05	0.000279	CcSEcCtD
Lansoprazole—Nausea—Brimonidine—glaucoma	5.77e-05	0.000278	CcSEcCtD
Lansoprazole—Feeling abnormal—Clonidine—glaucoma	5.76e-05	0.000278	CcSEcCtD
Lansoprazole—Rash—Brinzolamide—glaucoma	5.75e-05	0.000277	CcSEcCtD
Lansoprazole—Vision blurred—Timolol—glaucoma	5.74e-05	0.000277	CcSEcCtD
Lansoprazole—Dermatitis—Brinzolamide—glaucoma	5.74e-05	0.000277	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Clonidine—glaucoma	5.72e-05	0.000276	CcSEcCtD
Lansoprazole—Headache—Brinzolamide—glaucoma	5.71e-05	0.000275	CcSEcCtD
Lansoprazole—Hypotension—Betaxolol—glaucoma	5.69e-05	0.000274	CcSEcCtD
Lansoprazole—Angioedema—Timolol—glaucoma	5.57e-05	0.000269	CcSEcCtD
Lansoprazole—Vomiting—Pilocarpine—glaucoma	5.57e-05	0.000269	CcSEcCtD
Lansoprazole—Urticaria—Clonidine—glaucoma	5.56e-05	0.000268	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Betaxolol—glaucoma	5.55e-05	0.000268	CcSEcCtD
Lansoprazole—Body temperature increased—Clonidine—glaucoma	5.53e-05	0.000267	CcSEcCtD
Lansoprazole—Abdominal pain—Clonidine—glaucoma	5.53e-05	0.000267	CcSEcCtD
Lansoprazole—Rash—Pilocarpine—glaucoma	5.52e-05	0.000266	CcSEcCtD
Lansoprazole—Dermatitis—Pilocarpine—glaucoma	5.52e-05	0.000266	CcSEcCtD
Lansoprazole—Insomnia—Betaxolol—glaucoma	5.51e-05	0.000266	CcSEcCtD
Lansoprazole—Nausea—Dorzolamide—glaucoma	5.51e-05	0.000265	CcSEcCtD
Lansoprazole—Headache—Pilocarpine—glaucoma	5.49e-05	0.000265	CcSEcCtD
Lansoprazole—Nausea—Travoprost—glaucoma	5.48e-05	0.000264	CcSEcCtD
Lansoprazole—Vertigo—Timolol—glaucoma	5.48e-05	0.000264	CcSEcCtD
Lansoprazole—Paraesthesia—Betaxolol—glaucoma	5.47e-05	0.000264	CcSEcCtD
Lansoprazole—Syncope—Timolol—glaucoma	5.47e-05	0.000264	CcSEcCtD
Lansoprazole—Dyspnoea—Betaxolol—glaucoma	5.43e-05	0.000262	CcSEcCtD
Lansoprazole—Nausea—Brinzolamide—glaucoma	5.41e-05	0.000261	CcSEcCtD
Lansoprazole—Palpitations—Timolol—glaucoma	5.39e-05	0.00026	CcSEcCtD
Lansoprazole—Dyspepsia—Betaxolol—glaucoma	5.36e-05	0.000258	CcSEcCtD
Lansoprazole—Loss of consciousness—Timolol—glaucoma	5.36e-05	0.000258	CcSEcCtD
Lansoprazole—Cough—Timolol—glaucoma	5.32e-05	0.000256	CcSEcCtD
Lansoprazole—Decreased appetite—Betaxolol—glaucoma	5.29e-05	0.000255	CcSEcCtD
Lansoprazole—Hypertension—Timolol—glaucoma	5.26e-05	0.000254	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Betaxolol—glaucoma	5.26e-05	0.000254	CcSEcCtD
Lansoprazole—Fatigue—Betaxolol—glaucoma	5.25e-05	0.000253	CcSEcCtD
Lansoprazole—Pain—Betaxolol—glaucoma	5.21e-05	0.000251	CcSEcCtD
Lansoprazole—Constipation—Betaxolol—glaucoma	5.21e-05	0.000251	CcSEcCtD
Lansoprazole—Nausea—Pilocarpine—glaucoma	5.2e-05	0.000251	CcSEcCtD
Lansoprazole—Arthralgia—Timolol—glaucoma	5.19e-05	0.00025	CcSEcCtD
Lansoprazole—Myalgia—Timolol—glaucoma	5.19e-05	0.00025	CcSEcCtD
Lansoprazole—Chest pain—Timolol—glaucoma	5.19e-05	0.00025	CcSEcCtD
Lansoprazole—Anxiety—Timolol—glaucoma	5.17e-05	0.000249	CcSEcCtD
Lansoprazole—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	5.15e-05	0.000249	CcSEcCtD
Lansoprazole—Hypersensitivity—Clonidine—glaucoma	5.15e-05	0.000248	CcSEcCtD
Lansoprazole—Discomfort—Timolol—glaucoma	5.13e-05	0.000247	CcSEcCtD
Lansoprazole—Dry mouth—Timolol—glaucoma	5.08e-05	0.000245	CcSEcCtD
Lansoprazole—Asthenia—Clonidine—glaucoma	5.02e-05	0.000242	CcSEcCtD
Lansoprazole—Feeling abnormal—Betaxolol—glaucoma	5.02e-05	0.000242	CcSEcCtD
Lansoprazole—Confusional state—Timolol—glaucoma	5.02e-05	0.000242	CcSEcCtD
Lansoprazole—Anaphylactic shock—Timolol—glaucoma	4.97e-05	0.00024	CcSEcCtD
Lansoprazole—Oedema—Timolol—glaucoma	4.97e-05	0.00024	CcSEcCtD
Lansoprazole—Pruritus—Clonidine—glaucoma	4.95e-05	0.000239	CcSEcCtD
Lansoprazole—Infection—Timolol—glaucoma	4.94e-05	0.000238	CcSEcCtD
Lansoprazole—Shock—Timolol—glaucoma	4.89e-05	0.000236	CcSEcCtD
Lansoprazole—Nervous system disorder—Timolol—glaucoma	4.88e-05	0.000235	CcSEcCtD
Lansoprazole—Urticaria—Betaxolol—glaucoma	4.84e-05	0.000233	CcSEcCtD
Lansoprazole—Skin disorder—Timolol—glaucoma	4.83e-05	0.000233	CcSEcCtD
Lansoprazole—Body temperature increased—Betaxolol—glaucoma	4.81e-05	0.000232	CcSEcCtD
Lansoprazole—Hyperhidrosis—Timolol—glaucoma	4.81e-05	0.000232	CcSEcCtD
Lansoprazole—Diarrhoea—Clonidine—glaucoma	4.79e-05	0.000231	CcSEcCtD
Lansoprazole—Anorexia—Timolol—glaucoma	4.74e-05	0.000229	CcSEcCtD
Lansoprazole—Hypotension—Timolol—glaucoma	4.65e-05	0.000224	CcSEcCtD
Lansoprazole—Dizziness—Clonidine—glaucoma	4.63e-05	0.000223	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Timolol—glaucoma	4.53e-05	0.000219	CcSEcCtD
Lansoprazole—Insomnia—Timolol—glaucoma	4.5e-05	0.000217	CcSEcCtD
Lansoprazole—Hypersensitivity—Betaxolol—glaucoma	4.49e-05	0.000216	CcSEcCtD
Lansoprazole—Paraesthesia—Timolol—glaucoma	4.47e-05	0.000215	CcSEcCtD
Lansoprazole—Vomiting—Clonidine—glaucoma	4.45e-05	0.000214	CcSEcCtD
Lansoprazole—Dyspnoea—Timolol—glaucoma	4.44e-05	0.000214	CcSEcCtD
Lansoprazole—Somnolence—Timolol—glaucoma	4.42e-05	0.000213	CcSEcCtD
Lansoprazole—Rash—Clonidine—glaucoma	4.41e-05	0.000213	CcSEcCtD
Lansoprazole—Dermatitis—Clonidine—glaucoma	4.41e-05	0.000212	CcSEcCtD
Lansoprazole—Headache—Clonidine—glaucoma	4.38e-05	0.000211	CcSEcCtD
Lansoprazole—Dyspepsia—Timolol—glaucoma	4.38e-05	0.000211	CcSEcCtD
Lansoprazole—Asthenia—Betaxolol—glaucoma	4.37e-05	0.000211	CcSEcCtD
Lansoprazole—Decreased appetite—Timolol—glaucoma	4.32e-05	0.000209	CcSEcCtD
Lansoprazole—Pruritus—Betaxolol—glaucoma	4.31e-05	0.000208	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Timolol—glaucoma	4.3e-05	0.000207	CcSEcCtD
Lansoprazole—Fatigue—Timolol—glaucoma	4.29e-05	0.000207	CcSEcCtD
Lansoprazole—Pain—Timolol—glaucoma	4.25e-05	0.000205	CcSEcCtD
Lansoprazole—Diarrhoea—Betaxolol—glaucoma	4.17e-05	0.000201	CcSEcCtD
Lansoprazole—Nausea—Clonidine—glaucoma	4.15e-05	0.0002	CcSEcCtD
Lansoprazole—Feeling abnormal—Timolol—glaucoma	4.1e-05	0.000198	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Timolol—glaucoma	4.07e-05	0.000196	CcSEcCtD
Lansoprazole—CYP2C18—Metabolism—CA2—glaucoma	4.05e-05	0.000899	CbGpPWpGaD
Lansoprazole—ABCB1—Transmembrane transport of small molecules—SLC4A4—glaucoma	4.04e-05	0.000895	CbGpPWpGaD
Lansoprazole—Dizziness—Betaxolol—glaucoma	4.03e-05	0.000194	CcSEcCtD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—CTSA—glaucoma	4.01e-05	0.000889	CbGpPWpGaD
Lansoprazole—Urticaria—Timolol—glaucoma	3.95e-05	0.000191	CcSEcCtD
Lansoprazole—Abdominal pain—Timolol—glaucoma	3.93e-05	0.00019	CcSEcCtD
Lansoprazole—Body temperature increased—Timolol—glaucoma	3.93e-05	0.00019	CcSEcCtD
Lansoprazole—Vomiting—Betaxolol—glaucoma	3.87e-05	0.000187	CcSEcCtD
Lansoprazole—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—glaucoma	3.87e-05	0.000857	CbGpPWpGaD
Lansoprazole—Rash—Betaxolol—glaucoma	3.84e-05	0.000185	CcSEcCtD
Lansoprazole—Dermatitis—Betaxolol—glaucoma	3.84e-05	0.000185	CcSEcCtD
Lansoprazole—CYP2C19—Biological oxidations—CYP1B1—glaucoma	3.83e-05	0.00085	CbGpPWpGaD
Lansoprazole—Headache—Betaxolol—glaucoma	3.82e-05	0.000184	CcSEcCtD
Lansoprazole—CYP2C19—Metapathway biotransformation—CYP1B1—glaucoma	3.78e-05	0.000838	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—NARFL—glaucoma	3.78e-05	0.000837	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—CA5A—glaucoma	3.78e-05	0.000837	CbGpPWpGaD
Lansoprazole—CYP1A2—Biological oxidations—GSTT1—glaucoma	3.75e-05	0.000831	CbGpPWpGaD
Lansoprazole—CYP1A1—Biological oxidations—GSTM1—glaucoma	3.74e-05	0.00083	CbGpPWpGaD
Lansoprazole—CYP1A1—Metapathway biotransformation—GSTM1—glaucoma	3.69e-05	0.000819	CbGpPWpGaD
Lansoprazole—Hypersensitivity—Timolol—glaucoma	3.67e-05	0.000177	CcSEcCtD
Lansoprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—glaucoma	3.66e-05	0.000812	CbGpPWpGaD
Lansoprazole—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	3.66e-05	0.000812	CbGpPWpGaD
Lansoprazole—ABCG2—Transmembrane transport of small molecules—SLC6A1—glaucoma	3.65e-05	0.000808	CbGpPWpGaD
Lansoprazole—Nausea—Betaxolol—glaucoma	3.62e-05	0.000174	CcSEcCtD
Lansoprazole—CYP1A2—Arachidonic acid metabolism—PTGS2—glaucoma	3.62e-05	0.000802	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—CTSA—glaucoma	3.58e-05	0.000794	CbGpPWpGaD
Lansoprazole—Asthenia—Timolol—glaucoma	3.57e-05	0.000172	CcSEcCtD
Lansoprazole—CYP2D6—Biological oxidations—CYP1B1—glaucoma	3.53e-05	0.000782	CbGpPWpGaD
Lansoprazole—Pruritus—Timolol—glaucoma	3.52e-05	0.00017	CcSEcCtD
Lansoprazole—CYP2C9—Biological oxidations—CYP1B1—glaucoma	3.5e-05	0.000775	CbGpPWpGaD
Lansoprazole—CYP2D6—Metapathway biotransformation—CYP1B1—glaucoma	3.48e-05	0.000771	CbGpPWpGaD
Lansoprazole—CYP2C9—Metapathway biotransformation—CYP1B1—glaucoma	3.45e-05	0.000764	CbGpPWpGaD
Lansoprazole—CYP2C8—Biological oxidations—GSTM1—glaucoma	3.43e-05	0.000761	CbGpPWpGaD
Lansoprazole—Diarrhoea—Timolol—glaucoma	3.4e-05	0.000164	CcSEcCtD
Lansoprazole—CYP2C8—Metapathway biotransformation—GSTM1—glaucoma	3.39e-05	0.000751	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—NARFL—glaucoma	3.37e-05	0.000747	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—CA5A—glaucoma	3.37e-05	0.000747	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—NARFL—glaucoma	3.29e-05	0.00073	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—CA5A—glaucoma	3.29e-05	0.00073	CbGpPWpGaD
Lansoprazole—Dizziness—Timolol—glaucoma	3.29e-05	0.000159	CcSEcCtD
Lansoprazole—CYP1B1—Metabolism—CA1—glaucoma	3.27e-05	0.000724	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—TXN—glaucoma	3.27e-05	0.000724	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—CTSA—glaucoma	3.27e-05	0.000724	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—CTSA—glaucoma	3.16e-05	0.000702	CbGpPWpGaD
Lansoprazole—Vomiting—Timolol—glaucoma	3.16e-05	0.000153	CcSEcCtD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	3.15e-05	0.000698	CbGpPWpGaD
Lansoprazole—Rash—Timolol—glaucoma	3.14e-05	0.000151	CcSEcCtD
Lansoprazole—Dermatitis—Timolol—glaucoma	3.13e-05	0.000151	CcSEcCtD
Lansoprazole—Headache—Timolol—glaucoma	3.12e-05	0.00015	CcSEcCtD
Lansoprazole—CYP2D6—Metabolism—CA5A—glaucoma	3.1e-05	0.000687	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—NARFL—glaucoma	3.1e-05	0.000687	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—NARFL—glaucoma	3.07e-05	0.000682	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—CA5A—glaucoma	3.07e-05	0.000682	CbGpPWpGaD
Lansoprazole—CYP2C19—Biological oxidations—GSTM1—glaucoma	3.06e-05	0.000679	CbGpPWpGaD
Lansoprazole—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	3.05e-05	0.000675	CbGpPWpGaD
Lansoprazole—CYP2C19—Metapathway biotransformation—GSTM1—glaucoma	3.02e-05	0.00067	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—CA2—glaucoma	2.99e-05	0.000662	CbGpPWpGaD
Lansoprazole—CYP1A2—Biological oxidations—CYP1B1—glaucoma	2.99e-05	0.000662	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism of lipids and lipoproteins—APOE—glaucoma	2.98e-05	0.000661	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—CA1—glaucoma	2.97e-05	0.000659	CbGpPWpGaD
Lansoprazole—Nausea—Timolol—glaucoma	2.96e-05	0.000142	CcSEcCtD
Lansoprazole—CYP4A11—Metabolism of lipids and lipoproteins—CAV1—glaucoma	2.95e-05	0.000655	CbGpPWpGaD
Lansoprazole—CYP1A2—Metapathway biotransformation—CYP1B1—glaucoma	2.95e-05	0.000653	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	2.92e-05	0.000647	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	2.9e-05	0.000643	CbGpPWpGaD
Lansoprazole—CYP3A4—Biological oxidations—GSTT1—glaucoma	2.89e-05	0.000641	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	2.88e-05	0.000639	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—CTSA—glaucoma	2.88e-05	0.000638	CbGpPWpGaD
Lansoprazole—ABCB1—HIF-1-alpha transcription factor network—VEGFA—glaucoma	2.86e-05	0.000634	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—TXN—glaucoma	2.86e-05	0.000633	CbGpPWpGaD
Lansoprazole—CYP2D6—Biological oxidations—GSTM1—glaucoma	2.82e-05	0.000625	CbGpPWpGaD
Lansoprazole—CYP2C9—Biological oxidations—GSTM1—glaucoma	2.79e-05	0.000619	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—CTSA—glaucoma	2.79e-05	0.000619	CbGpPWpGaD
Lansoprazole—CYP2D6—Metapathway biotransformation—GSTM1—glaucoma	2.78e-05	0.000616	CbGpPWpGaD
Lansoprazole—CYP2C9—Metapathway biotransformation—GSTM1—glaucoma	2.76e-05	0.000611	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—CA2—glaucoma	2.72e-05	0.000603	CbGpPWpGaD
Lansoprazole—ABCB1—Transmembrane transport of small molecules—SLC6A13—glaucoma	2.69e-05	0.000597	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—CA5A—glaucoma	2.63e-05	0.000582	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—NARFL—glaucoma	2.63e-05	0.000582	CbGpPWpGaD
Lansoprazole—CYP1A2—Aryl Hydrocarbon Receptor—TNF—glaucoma	2.61e-05	0.000579	CbGpPWpGaD
Lansoprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—glaucoma	2.61e-05	0.000579	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—GSTT1—glaucoma	2.53e-05	0.000562	CbGpPWpGaD
Lansoprazole—ABCB1—Allograft Rejection—VEGFA—glaucoma	2.48e-05	0.000549	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	2.47e-05	0.000547	CbGpPWpGaD
Lansoprazole—CYP1A2—Biological oxidations—GSTM1—glaucoma	2.39e-05	0.000529	CbGpPWpGaD
Lansoprazole—CYP1A2—Metapathway biotransformation—GSTM1—glaucoma	2.35e-05	0.000522	CbGpPWpGaD
Lansoprazole—CYP3A4—Biological oxidations—CYP1B1—glaucoma	2.31e-05	0.000511	CbGpPWpGaD
Lansoprazole—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	2.27e-05	0.000504	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—GSTT1—glaucoma	2.21e-05	0.000491	CbGpPWpGaD
Lansoprazole—ABCB1—Allograft Rejection—TNF—glaucoma	2.12e-05	0.00047	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	2.11e-05	0.000467	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—TXN—glaucoma	2.11e-05	0.000467	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	2.04e-05	0.000453	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CA5A—glaucoma	2.03e-05	0.000449	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—NARFL—glaucoma	2.03e-05	0.000449	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—ABCA1—glaucoma	2.02e-05	0.000447	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—CYP1B1—glaucoma	2.02e-05	0.000447	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—CA1—glaucoma	2.01e-05	0.000446	CbGpPWpGaD
Lansoprazole—ABCB1—Transmembrane transport of small molecules—SLC6A1—glaucoma	1.97e-05	0.000437	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—CTSA—glaucoma	1.95e-05	0.000432	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.92e-05	0.000426	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—TXN—glaucoma	1.92e-05	0.000425	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.9e-05	0.000422	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—CA1—glaucoma	1.84e-05	0.000409	CbGpPWpGaD
Lansoprazole—CYP3A4—Biological oxidations—GSTM1—glaucoma	1.84e-05	0.000409	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—CA2—glaucoma	1.84e-05	0.000408	CbGpPWpGaD
Lansoprazole—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	1.82e-05	0.000403	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.8e-05	0.000399	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.8e-05	0.000399	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—CTSA—glaucoma	1.79e-05	0.000396	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—ABCA1—glaucoma	1.76e-05	0.000391	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—CYP1B1—glaucoma	1.76e-05	0.000391	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—CA2—glaucoma	1.69e-05	0.000374	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.65e-05	0.000366	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.65e-05	0.000366	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—CA1—glaucoma	1.65e-05	0.000365	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—GSTT1—glaucoma	1.63e-05	0.000362	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—GSTM1—glaucoma	1.61e-05	0.000358	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—CA1—glaucoma	1.61e-05	0.000356	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—CTSA—glaucoma	1.59e-05	0.000354	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—CTSA—glaucoma	1.56e-05	0.000345	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	1.55e-05	0.000344	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—CA1—glaucoma	1.51e-05	0.000336	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—CA2—glaucoma	1.51e-05	0.000334	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—CA1—glaucoma	1.5e-05	0.000333	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—GSTT1—glaucoma	1.49e-05	0.000329	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.47e-05	0.000326	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.47e-05	0.000326	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—CA2—glaucoma	1.47e-05	0.000326	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	1.47e-05	0.000326	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—CTSA—glaucoma	1.47e-05	0.000325	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—CTSA—glaucoma	1.45e-05	0.000322	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—MTHFR—glaucoma	1.43e-05	0.000316	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—GSTM1—glaucoma	1.41e-05	0.000313	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—CA2—glaucoma	1.39e-05	0.000307	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—CA2—glaucoma	1.37e-05	0.000304	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.34e-05	0.000298	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.34e-05	0.000298	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—APOE—glaucoma	1.33e-05	0.000294	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.32e-05	0.000292	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—CAV1—glaucoma	1.32e-05	0.000292	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—ABCA1—glaucoma	1.3e-05	0.000288	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—TXN—glaucoma	1.3e-05	0.000287	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—CA1—glaucoma	1.28e-05	0.000284	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—MTHFR—glaucoma	1.25e-05	0.000276	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—CTSA—glaucoma	1.24e-05	0.000275	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	1.22e-05	0.000271	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—TXN—glaucoma	1.19e-05	0.000264	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—ABCA1—glaucoma	1.18e-05	0.000262	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—CYP1B1—glaucoma	1.18e-05	0.000262	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.18e-05	0.000262	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—CA2—glaucoma	1.17e-05	0.00026	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.17e-05	0.00026	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—APOE—glaucoma	1.16e-05	0.000257	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—CAV1—glaucoma	1.15e-05	0.000255	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.15e-05	0.000254	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.15e-05	0.000254	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.08e-05	0.00024	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.07e-05	0.000238	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—TXN—glaucoma	1.06e-05	0.000235	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	1.05e-05	0.000232	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—GSTM1—glaucoma	1.04e-05	0.000231	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—TXN—glaucoma	1.04e-05	0.00023	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—GSTT1—glaucoma	1.01e-05	0.000223	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—NOS3—glaucoma	9.95e-06	0.000221	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CA1—glaucoma	9.9e-06	0.00022	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—TXN—glaucoma	9.76e-06	0.000216	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—APOE—glaucoma	9.68e-06	0.000215	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—TXN—glaucoma	9.67e-06	0.000214	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—glaucoma	9.59e-06	0.000213	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CTSA—glaucoma	9.59e-06	0.000213	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—GSTM1—glaucoma	9.46e-06	0.00021	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	9.23e-06	0.000205	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—GSTT1—glaucoma	9.22e-06	0.000204	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—MTHFR—glaucoma	9.19e-06	0.000204	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—PTGS2—glaucoma	9.1e-06	0.000202	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CA2—glaucoma	9.06e-06	0.000201	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—APOE—glaucoma	8.83e-06	0.000196	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—glaucoma	8.75e-06	0.000194	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—NOS3—glaucoma	8.69e-06	0.000193	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—APOE—glaucoma	8.56e-06	0.00019	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—CAV1—glaucoma	8.48e-06	0.000188	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—MTHFR—glaucoma	8.36e-06	0.000185	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—TXN—glaucoma	8.27e-06	0.000183	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—GSTT1—glaucoma	8.23e-06	0.000182	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	8.11e-06	0.00018	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—GSTT1—glaucoma	8.03e-06	0.000178	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—ABCA1—glaucoma	8.01e-06	0.000178	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—CYP1B1—glaucoma	8.01e-06	0.000178	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—PTGS2—glaucoma	7.95e-06	0.000176	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—APOE—glaucoma	7.78e-06	0.000173	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—CAV1—glaucoma	7.71e-06	0.000171	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—GSTT1—glaucoma	7.57e-06	0.000168	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—APOE—glaucoma	7.54e-06	0.000167	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—GSTT1—glaucoma	7.5e-06	0.000166	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	7.47e-06	0.000166	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	7.43e-06	0.000165	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—ABCA1—glaucoma	7.34e-06	0.000163	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—CYP1B1—glaucoma	7.34e-06	0.000163	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	6.63e-06	0.000147	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—ABCA1—glaucoma	6.56e-06	0.000145	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—CYP1B1—glaucoma	6.56e-06	0.000145	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—GSTT1—glaucoma	6.41e-06	0.000142	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—NOS3—glaucoma	6.41e-06	0.000142	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—GSTM1—glaucoma	6.4e-06	0.000142	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—CYP1B1—glaucoma	6.4e-06	0.000142	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—ABCA1—glaucoma	6.4e-06	0.000142	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—TXN—glaucoma	6.38e-06	0.000141	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	6.05e-06	0.000134	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—ABCA1—glaucoma	6.03e-06	0.000134	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—CYP1B1—glaucoma	6.03e-06	0.000134	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—ABCA1—glaucoma	5.98e-06	0.000133	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—CYP1B1—glaucoma	5.98e-06	0.000133	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—GSTM1—glaucoma	5.87e-06	0.00013	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—PTGS2—glaucoma	5.86e-06	0.00013	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—NOS3—glaucoma	5.83e-06	0.000129	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—MTHFR—glaucoma	5.66e-06	0.000125	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—PTGS2—glaucoma	5.33e-06	0.000118	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—APOE—glaucoma	5.27e-06	0.000117	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—GSTM1—glaucoma	5.24e-06	0.000116	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—CAV1—glaucoma	5.22e-06	0.000116	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—MTHFR—glaucoma	5.19e-06	0.000115	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	5.17e-06	0.000115	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—GSTM1—glaucoma	5.11e-06	0.000113	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—CYP1B1—glaucoma	5.11e-06	0.000113	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—ABCA1—glaucoma	5.11e-06	0.000113	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—GSTT1—glaucoma	4.95e-06	0.00011	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—APOE—glaucoma	4.83e-06	0.000107	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—GSTM1—glaucoma	4.82e-06	0.000107	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—CAV1—glaucoma	4.79e-06	0.000106	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—GSTM1—glaucoma	4.78e-06	0.000106	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—MTHFR—glaucoma	4.63e-06	0.000103	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—MTHFR—glaucoma	4.52e-06	0.0001	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—APOE—glaucoma	4.31e-06	9.56e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—CAV1—glaucoma	4.27e-06	9.47e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—MTHFR—glaucoma	4.26e-06	9.44e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—MTHFR—glaucoma	4.22e-06	9.36e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—APOE—glaucoma	4.21e-06	9.33e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—CAV1—glaucoma	4.17e-06	9.24e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—GSTM1—glaucoma	4.08e-06	9.05e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—APOE—glaucoma	3.97e-06	8.79e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—NOS3—glaucoma	3.95e-06	8.75e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CYP1B1—glaucoma	3.94e-06	8.74e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—ABCA1—glaucoma	3.94e-06	8.74e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—APOE—glaucoma	3.93e-06	8.72e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—CAV1—glaucoma	3.93e-06	8.71e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—CAV1—glaucoma	3.9e-06	8.64e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—NOS3—glaucoma	3.62e-06	8.02e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PTGS2—glaucoma	3.61e-06	8e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—MTHFR—glaucoma	3.61e-06	8e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—APOE—glaucoma	3.36e-06	7.45e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—CAV1—glaucoma	3.33e-06	7.38e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PTGS2—glaucoma	3.31e-06	7.34e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—NOS3—glaucoma	3.23e-06	7.16e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—NOS3—glaucoma	3.15e-06	6.99e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—GSTM1—glaucoma	3.15e-06	6.99e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—NOS3—glaucoma	2.97e-06	6.59e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PTGS2—glaucoma	2.95e-06	6.55e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—NOS3—glaucoma	2.95e-06	6.53e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PTGS2—glaucoma	2.88e-06	6.39e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—MTHFR—glaucoma	2.79e-06	6.17e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PTGS2—glaucoma	2.72e-06	6.02e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PTGS2—glaucoma	2.69e-06	5.97e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—APOE—glaucoma	2.59e-06	5.75e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CAV1—glaucoma	2.57e-06	5.69e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—NOS3—glaucoma	2.52e-06	5.58e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PTGS2—glaucoma	2.3e-06	5.1e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—NOS3—glaucoma	1.94e-06	4.31e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PTGS2—glaucoma	1.78e-06	3.94e-05	CbGpPWpGaD
